Partnership Opportunities

You are creating the future of personalized care. Biocept can help.

Explore Partnership Opportunities

Our experience includes working with pharmaceutical companies, major cancer centers, CROs, diagnostic firms and other testing laboratories on projects of various types.

We bring creativity, customization, and responsiveness to all of our projects, seeking to best address our clients’ needs and help improve outcomes. We offer superb flexibility when designing and structuring projects.

Our proprietary technologies are focused on CTC and ctDNA biomarker analysis. With expertise in both specimens, Biocept can utilize technologies such as Immunocytochemistry, FISH, PCR, and Next Generation Sequencing to analyze alterations in both protein and DNA– all from the same sample. Sample types could include blood, bone marrow, urine, cerebrospinal fluid or saliva.

Our technical team is experienced in all aspects of rare cell and cell-free DNA research and testing, and this core competency allows us to develop collaborations aligned with our clients’ goals and interests.

Please contact Mike Terry, Senior Vice President, Corporate Development, for more information at 858.320.8200 Ext. 297 or via email at mterry@biocept.com.

Technology

Capture More CTCs with Biocept’s Unique Technology

Biocept has developed an advanced method for capturing CTCs from a blood sample, using a novel microfluidic device and antibody capture cocktail for maximum sensitivity.

Services

Capture More CTCs with Biocept’s Unique Technology

Biocept works with you to customize a CTC capture and analysis protocol that meets your unique needs, including:

  • Assay development
  • Analysis of established and novel biomarkers
  • Patient population profiling
  • Correlative science studies
  • Patient eligibility / stratification for clinical trials
  • Measurement of efficacy endpoints
Our Partners

Who We Work With

  • Pharmaceutical and biotechnology companies
  • Leading academic research and cancer centers
  • Contract research organizations (CROs)
  • Diagnostic firms
Partner with Biocept

Contact us to learn how Biocept can support your research and testing.

Contact Mike Terry, Senior Vice President, Corporate Development, for more information at 858.320.8200 Ext. 297 or via email at mterry@biocept.com.